Enad Global 7 AB (publ)
Enad Global 7 AB (publ) (ENADF) Financial Performance & Income Statement Overview
Analyze Enad Global 7 AB (publ) (ENADF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Enad Global 7 AB (publ) (ENADF) Income Statement & Financial Overview
Review Enad Global 7 AB (publ) ENADF income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $461.20M | $668.30M | $469.20M | $352.70M |
| Cost of Revenue | $130.80M | $127.10M | $95.60M | $381.30M |
| Gross Profit | $330.40M | $541.20M | $373.60M | -$28.60M |
| Gross Profit Ratio | $0.72 | $0.81 | $0.80 | -$0.08 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $3.50M |
| SG&A Expenses | $267.00M | $269.00M | $298.40M | -$318.00M |
| Operating Expenses | $340.50M | $689.60M | $378.10M | $3.50M |
| Total Costs & Expenses | $471.30M | $816.70M | $473.70M | $384.80M |
| Interest Income | $2.00M | $8.60M | $1.40M | $2.20M |
| Interest Expense | $5.10M | $9.40M | $8.70M | $9.00M |
| Depreciation & Amortization | $72.20M | $423.40M | $78.30M | $49.50M |
| EBITDA | $64.10M | $282.30M | $73.40M | $20.60M |
| EBITDA Ratio | $0.14 | $0.42 | $0.16 | $0.06 |
| Operating Income | -$10.10M | -$148.40M | -$4.50M | -$25.90M |
| Operating Income Ratio | -$0.02 | -$0.22 | -$0.010 | -$0.07 |
| Other Income/Expenses (Net) | -$3.10M | -$2.10M | -$9.00M | -$7.50M |
| Income Before Tax | -$13.20M | -$150.50M | -$13.50M | -$33.40M |
| Income Before Tax Ratio | -$0.03 | -$0.23 | -$0.03 | -$0.09 |
| Income Tax Expense | $5.40M | $33.00M | $15.70M | $5.40M |
| Net Income | -$18.50M | -$183.50M | -$29.20M | -$38.80M |
| Net Income Ratio | -$0.04 | -$0.27 | -$0.06 | -$0.11 |
| EPS | -$0.21 | -$2.07 | -$0.33 | -$0.44 |
| Diluted EPS | -$0.21 | -$2.07 | -$0.33 | -$0.44 |
| Weighted Avg Shares Outstanding | $88.60M | $88.60M | $88.60M | $88.60M |
| Weighted Avg Shares Outstanding (Diluted) | $88.60M | $88.60M | $88.60M | $88.60M |
The company's financials show resilient growth, with revenue advancing from $352.70M in Q2 2024 to $461.20M in Q1 2025. Gross profit remained healthy with margins at 72% in Q1 2025 compared to -8% in Q2 2024. Operating income hit -$10.10M last quarter, sustaining a consistent -2% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $64.10M. Net income rose to -$18.50M, while earnings per share reached -$0.21. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan